 Bio-Rad Laboratories continues to report impressive earnings and has been on a winning streak with nearly two years of strong beats on EPS and revenue. The companys expansive product portfolio has facilitated growth during the pandemic. Now, both the Life Sciences and Clinical Diagnostics segments are showing sequential growth. 